Meeting to be held in Boston on January 28 hosted by B. Riley.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TBPH:
- Theravance Biopharma highlights cash-generation, YUPELRI growth, ampreloxetine
- Theravance Biopharma’s Ampreloxetine: A Promising Candidate for Neurogenic Orthostatic Hypotension with Strong Market Potential
- Theravance Biopharma’s Ampreloxetine: A Promising Solution for MSA with Strategic Market Positioning
- Theravance Biopharma’s Ampreloxetine: A Promising Treatment for Neurogenic Orthostatic Hypotension with Strong Commercial Prospects
- Theravance Biopharma Hosts Key Opinion Leader Event